AI drug discovery company

Converge Bio

Data as of Oct 17, 2026.

Company facts

Founded

2024

ReportedSource for founded (opens in new tab)
Headquarters

Israel (Tel Aviv) and United States (Boston)

ConfirmedSource for headquarters (opens in new tab)
Total funding

$30M

ConfirmedSource for total funding (opens in new tab)

Latest funding round

Round: Series A
Date: Jan 13, 2026
Amount: $25M
Lead investor: Bessemer Venture Partners

ConfirmedSource for the latest round (opens in new tab)

Drug discovery partners

0 pharma, 1 other. Pharma here means a company with approved products and roughly $1B or more in annual revenue.

Purple Biotech Biotech

AI collaboration on tri-specific antibody platform, Mar 25, 2026

Terms not disclosed

ConfirmedSource for Purple Biotech (opens in new tab)

Recent news

Mar 25, 2026

Purple Biotech AI collaboration on its tri-specific antibody platform

ConfirmedSource (opens in new tab)
Jan 13, 2026

Raises a $25M Series A led by Bessemer Venture Partners

ConfirmedSource (opens in new tab)

Confirmed means the company, a partner or a filing said it. Reported means a third party said it. This section sits outside the Pharma AI Tracker.

Spot an error? Tell me and I'll fix it.